Combined analysis of studies of the effects of the matrix metalloproteinase inhibitor marimastat on serum tumor markers in advanced cancer: selection of a biologically active and tolerable dose for longer-term studies.
Year: 1998
Type: article
Source: PubMed
Authors: J Nemunaitis, C Poole, J Primrose, A Rosemurgy, J Malfetano, P Brown, A Berrington, A Cornish, K Lynch, H Rasmussen, D Kerr, D Cox, A Millar
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2159818315